furosemide has been researched along with Albuminuria in 22 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Albuminuria: The presence of albumin in the urine, an indicator of KIDNEY DISEASES.
Excerpt | Relevance | Reference |
---|---|---|
"In patients with nephrotic syndrome, the natriuretic effect of furosemide (FU) is diminished." | 9.09 | Coadministration of albumin and furosemide in patients with the nephrotic syndrome. ( Bischoff, I; Fliser, D; Franek, E; Mutschler, E; Nussberger, J; Ritz, E; Zurbrüggen, I, 1999) |
"To examine the factors that determine the blood pressure response to enalapril and nifedipine monotherapy in the treatment of hypertension associated with non-insulin-dependent diabetes mellitus (NIDDM)." | 9.08 | Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM. ( Chan, JC; Cheung, CK; Cockram, CS; Law, LK; Nicholls, MG; Swaminathan, R, 1995) |
"To determine whether bucolome (5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine), a nonsteroidal anti-inflammatory agent, can reverse diuretic resistance of furosemide in patients with nephrotic syndrome, we examined the inhibitory effect of bucolome on the protein binding of furosemide in serum and urine." | 7.73 | Bucolome, a potent binding inhibitor for furosemide, alters the pharmacokinetics and diuretic effect of furosemide: potential for use of bucolome to restore diuretic response in nephrotic syndrome. ( Chosa, E; Deguchi, T; Kawai, K; Maruyama, T; Otagiri, M; Takamura, N; Tsutsumi, Y; Uryu, Y; Yamasaki, K, 2005) |
"Treatment with oral diazoxide for periods of 4 to 10 weeks in hospital allowed adequate control of hypertension with continuation of fetal growth in four patients with severe toxaemia." | 7.65 | Successful use of oral diazoxide in the treatment of severe toxaemia of pregnancy. ( Davis, D; Morgan, MY; Pohl, JE; Thurston, H, 1972) |
"Lacidipine was not very effective in controlling blood pressure and had an adverse effect on renal function." | 6.68 | Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency. ( Bailey, RR; Lynn, KL; Robson, RA; Shand, BI; Smith, AH, 1997) |
"Captopril is a valuable new drug for treating hypertension in insulin dependent diabetics with nephropathy." | 6.66 | Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. ( Hommel, E; Parving, HH; Smidt, UM, 1988) |
"In patients with nephrotic syndrome, the natriuretic effect of furosemide (FU) is diminished." | 5.09 | Coadministration of albumin and furosemide in patients with the nephrotic syndrome. ( Bischoff, I; Fliser, D; Franek, E; Mutschler, E; Nussberger, J; Ritz, E; Zurbrüggen, I, 1999) |
"To examine the factors that determine the blood pressure response to enalapril and nifedipine monotherapy in the treatment of hypertension associated with non-insulin-dependent diabetes mellitus (NIDDM)." | 5.08 | Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM. ( Chan, JC; Cheung, CK; Cockram, CS; Law, LK; Nicholls, MG; Swaminathan, R, 1995) |
"Given a similar level of arterial pressure control, both lisinopril and diltiazem slow progression of diabetic renal disease and reduce albuminuria to a greater extent than does the combination of a loop diuretic and beta-adrenoreceptor antagonist." | 5.07 | Comparative effects of different antihypertensive treatments on progression of diabetic renal disease. ( Bakris, GL; Sadler, R; Slataper, R; Vicknair, N, 1993) |
"We have previously shown that an association of losartan and hydrochlorothiazide, initiated 1 mo after 5/6 nephrectomy (Nx), reversed hypertension and albuminuria and promoted lasting renoprotection." | 3.83 | An association of losartan-hydrochlorothiazide, but not losartan-furosemide, completely arrests progressive injury in the remnant kidney. ( Arias, SC; Fanelli, C; Fujihara, CK; Malheiros, DM; Souza, RA; Zatz, R, 2016) |
"To determine whether bucolome (5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine), a nonsteroidal anti-inflammatory agent, can reverse diuretic resistance of furosemide in patients with nephrotic syndrome, we examined the inhibitory effect of bucolome on the protein binding of furosemide in serum and urine." | 3.73 | Bucolome, a potent binding inhibitor for furosemide, alters the pharmacokinetics and diuretic effect of furosemide: potential for use of bucolome to restore diuretic response in nephrotic syndrome. ( Chosa, E; Deguchi, T; Kawai, K; Maruyama, T; Otagiri, M; Takamura, N; Tsutsumi, Y; Uryu, Y; Yamasaki, K, 2005) |
"Treatment with oral diazoxide for periods of 4 to 10 weeks in hospital allowed adequate control of hypertension with continuation of fetal growth in four patients with severe toxaemia." | 3.65 | Successful use of oral diazoxide in the treatment of severe toxaemia of pregnancy. ( Davis, D; Morgan, MY; Pohl, JE; Thurston, H, 1972) |
"Lacidipine was not very effective in controlling blood pressure and had an adverse effect on renal function." | 2.68 | Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency. ( Bailey, RR; Lynn, KL; Robson, RA; Shand, BI; Smith, AH, 1997) |
"Captopril is a valuable new drug for treating hypertension in insulin dependent diabetics with nephropathy." | 2.66 | Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. ( Hommel, E; Parving, HH; Smidt, UM, 1988) |
"Eighteen hypertensive IDDM patients with diabetic nephropathy, who had not been treated previously, were followed during 3 years of treatment with captopril and frusemide or bendrofluazide." | 1.29 | Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. ( Hommel, E; Parving, HH; Rossing, P; Smidt, UM, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (50.00) | 18.7374 |
1990's | 8 (36.36) | 18.2507 |
2000's | 1 (4.55) | 29.6817 |
2010's | 2 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Koyner, JL | 1 |
Davison, DL | 1 |
Brasha-Mitchell, E | 1 |
Chalikonda, DM | 1 |
Arthur, JM | 1 |
Shaw, AD | 1 |
Tumlin, JA | 1 |
Trevino, SA | 1 |
Bennett, MR | 1 |
Kimmel, PL | 1 |
Seneff, MG | 1 |
Chawla, LS | 1 |
Arias, SC | 1 |
Souza, RA | 1 |
Malheiros, DM | 1 |
Fanelli, C | 1 |
Fujihara, CK | 1 |
Zatz, R | 1 |
Takamura, N | 1 |
Maruyama, T | 1 |
Chosa, E | 1 |
Kawai, K | 1 |
Tsutsumi, Y | 1 |
Uryu, Y | 1 |
Yamasaki, K | 1 |
Deguchi, T | 1 |
Otagiri, M | 1 |
Andreasen, F | 2 |
Hansen, U | 1 |
Husted, SE | 1 |
Mogensen, CE | 4 |
Christensen, CK | 2 |
Jacobsen, FK | 2 |
Jansen, J | 1 |
Pedersen, OL | 1 |
Christensen, NJ | 1 |
Gundersen, HJ | 1 |
Pedersen, EB | 1 |
Vittinghus, E | 1 |
Chan, JC | 1 |
Nicholls, MG | 1 |
Cheung, CK | 1 |
Law, LK | 1 |
Swaminathan, R | 1 |
Cockram, CS | 1 |
Parving, HH | 6 |
Rossing, P | 3 |
Hommel, E | 6 |
Smidt, UM | 4 |
Slataper, R | 1 |
Vicknair, N | 1 |
Sadler, R | 1 |
Bakris, GL | 1 |
Bailey, RR | 1 |
Shand, BI | 1 |
Smith, AH | 1 |
Robson, RA | 1 |
Lynn, KL | 1 |
Fliser, D | 1 |
Zurbrüggen, I | 1 |
Mutschler, E | 1 |
Bischoff, I | 1 |
Nussberger, J | 1 |
Franek, E | 1 |
Ritz, E | 1 |
First, MR | 1 |
Bramlage, RJ | 1 |
Pesce, AJ | 1 |
Pollak, VE | 1 |
Teschner, M | 1 |
Schaefer, RM | 1 |
Bahner, U | 1 |
Heidland, A | 1 |
Larsen, M | 1 |
Lund-Andersen, H | 1 |
Mathiesen, ER | 1 |
Sjöström, PA | 1 |
Odlind, BG | 1 |
Beermann, BA | 1 |
Karlberg, BE | 1 |
Pianetti, F | 1 |
Pohl, JE | 1 |
Thurston, H | 1 |
Davis, D | 1 |
Morgan, MY | 1 |
1 review available for furosemide and Albuminuria
Article | Year |
---|---|
[Nephropathy in type 1 diabetes mellitus. Current experimental and clinical aspects].
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Dia | 1992 |
9 trials available for furosemide and Albuminuria
Article | Year |
---|---|
Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Aged; Albuminuria; Biomarkers; Creatinine; Disease Progre | 2015 |
Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM.
Topics: Albuminuria; Aldosterone; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Glucose; Blood P | 1995 |
Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Bendroflumethiazide; Blood Pressure; C | 1995 |
Reduction in albuminuria predicts diminished progression in diabetic nephropathy.
Topics: Adult; Albuminuria; Antihypertensive Agents; Cohort Studies; Diabetic Nephropathies; Female; Forecas | 1994 |
Comparative effects of different antihypertensive treatments on progression of diabetic renal disease.
Topics: Albuminuria; Antihypertensive Agents; Atenolol; Diabetic Nephropathies; Diltiazem; Dipeptides; Furos | 1993 |
Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
Topics: Adult; Aged; Albuminuria; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydro | 1997 |
Coadministration of albumin and furosemide in patients with the nephrotic syndrome.
Topics: Adult; Albuminuria; Atrial Natriuretic Factor; Cross-Over Studies; Diuresis; Double-Blind Method; Dr | 1999 |
Pharmacokinetics and effects of frusemide in patients with the nephrotic syndrome.
Topics: Adult; Albuminuria; Chromatography, High Pressure Liquid; Electrolytes; Female; Furosemide; Humans; | 1989 |
Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.
Topics: Adult; Albuminuria; Bendroflumethiazide; Captopril; Clinical Trials as Topic; Diabetes Mellitus, Typ | 1988 |
12 other studies available for furosemide and Albuminuria
Article | Year |
---|---|
An association of losartan-hydrochlorothiazide, but not losartan-furosemide, completely arrests progressive injury in the remnant kidney.
Topics: Albuminuria; Animals; Blood Pressure; Drug Combinations; Furosemide; Hydrochlorothiazide; Hypertensi | 2016 |
Bucolome, a potent binding inhibitor for furosemide, alters the pharmacokinetics and diuretic effect of furosemide: potential for use of bucolome to restore diuretic response in nephrotic syndrome.
Topics: Adult; Albumins; Albuminuria; Animals; Anti-Inflammatory Agents, Non-Steroidal; Barbiturates; Blood | 2005 |
The influence of intravenous furosemide on the renal excretion pattern of protein and protein degradation products.
Topics: Aged; Aging; Albuminuria; beta 2-Microglobulin; Creatine; Furosemide; Humans; Hydrogen-Ion Concentra | 1984 |
The individual variation in pharmacokinetics and pharmacodynamics of furosemide in young normal male subjects.
Topics: Adult; Albuminuria; Blood Pressure; Creatinine; Furosemide; Humans; Kidney Function Tests; Kinetics; | 1982 |
Renal protein handling in normal, hypertensive and diabetic man.
Topics: Albuminuria; beta 2-Microglobulin; Diabetes Mellitus; Furosemide; Humans; Hypertension; Kidney; Kine | 1981 |
Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment.
Topics: Adult; Albuminuria; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Captopril; Diabete | 1994 |
Albumin excretion by the kidney: the effects of furosemide diuresis.
Topics: Albumins; Albuminuria; Animals; Diuresis; Female; Furosemide; Glomerular Filtration Rate; Kidney; Ra | 1978 |
Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment.
Topics: Adolescent; Adult; Albuminuria; Diabetic Nephropathies; Furosemide; Glomerular Filtration Rate; Huma | 1976 |
Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy.
Topics: Adult; Albuminuria; Bendroflumethiazide; Blood Glucose; Blood Pressure; Blood-Retinal Barrier; Capto | 1989 |
Converting enzyme-inhibition in diabetic nephropathy.
Topics: Albuminuria; Blood Pressure; Captopril; Diabetic Nephropathies; Drug Therapy, Combination; Furosemid | 1989 |
[Our results in the treatment of gestosic patients during labor in the 5-year period of 1966-1970].
Topics: Adult; Albuminuria; Edema; Female; Furosemide; Humans; Hypertension; Movement Disorders; Obstetric L | 1972 |
Successful use of oral diazoxide in the treatment of severe toxaemia of pregnancy.
Topics: Acute Disease; Administration, Oral; Adult; Albuminuria; Blood Glucose; Diazoxide; Female; Furosemid | 1972 |